Slimane Zerdoud

2.5k total citations · 1 hit paper
61 papers, 1.3k citations indexed

About

Slimane Zerdoud is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Slimane Zerdoud has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Surgery and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Slimane Zerdoud's work include Thyroid Cancer Diagnosis and Treatment (29 papers), Medical Imaging Techniques and Applications (10 papers) and Thyroid and Parathyroid Surgery (10 papers). Slimane Zerdoud is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (29 papers), Medical Imaging Techniques and Applications (10 papers) and Thyroid and Parathyroid Surgery (10 papers). Slimane Zerdoud collaborates with scholars based in France, Switzerland and Italy. Slimane Zerdoud's co-authors include Sophie Leboulleux, Claire Bournaud, Marie‐Elisabeth Toubert, Isabelle Borget, Désirèe Deandreis, Martin Schlumberger, Claire Schvartz, Danielle Benisvy, Bogdan Catargi and Stéphane Bardet and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Slimane Zerdoud

56 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

2012 448 citations Martin Schlumberger, Bogdan Catargi et al. profile →

Peers

Countries citing papers authored by Slimane Zerdoud

Since Specialization

Citations

This map shows the geographic impact of Slimane Zerdoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Slimane Zerdoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Slimane Zerdoud more than expected).

Fields of papers citing papers by Slimane Zerdoud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Slimane Zerdoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Slimane Zerdoud. The network helps show where Slimane Zerdoud may publish in the future.

Co-authorship network of co-authors of Slimane Zerdoud

This figure shows the co-authorship network connecting the top 25 collaborators of Slimane Zerdoud. A scholar is included among the top collaborators of Slimane Zerdoud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Slimane Zerdoud. Slimane Zerdoud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancer 2025 ·Annales d Endocrinologie ·Hélène Lasolle, Christine Do Cao, Livia Lamartina, (unknown), (unknown), Camille Buffet, Sophie Leboulleux, S. Hescot, Yann Godbert, Slimane Zerdoud, Renaud Ciappuccini, Arnaud Jannin, Julien Hadoux, Françoise Borson‐Chazot	0
2	Patients with medullary thyroid carcinoma and long term treatment with vandetanib: a study from the endocan -tuthyref network 2024 ·Endocrine Abstracts ·Hélène Lasolle, Livia Lamartina, (unknown), Camille Buffet, Olivier Schneegans, (unknown), D. Drui, Danielle Benisvy, (unknown), Yann Godbert, Stéphane Bardet, Marie Batisse‐Lignier, C. Chougnet, Slimane Zerdoud, Nathalie Roudaut, F. Illouz, Christophe Sajous, Julien Hadoux, (unknown), Françoise Borson‐Chazot	1
3	Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes 2022 ·The Breast ·(unknown), (unknown), Bastien Cabarrou, R. Aziza, Eva Jouve, Slimane Zerdoud, (unknown), Carole Massabeau, (unknown), (unknown), Mony Ung, Florence Dalenc, (unknown), C. Chira	5
4	Diagnosis, biology and epidemiology of oligometastatic breast cancer 2021 ·The Breast ·(unknown), R. Aziza, C. Chira, (unknown), (unknown), Eva Jouve, Carole Massabeau, Anne Pradines, (unknown), Mony Ung, Slimane Zerdoud, Florence Dalenc	6
5	RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer 2021 ·European Journal of Nuclear Medicine and Molecular Imaging ·Désirèe Deandreis, Aline Maillard, Slimane Zerdoud, Claire Bournaud, (unknown), Christophe Sajous, M. Terroir, Laurence Leenhardt, Martin Schlumberger, Isabelle Borget, Sophie Leboulleux	8
6	Génotypage moléculaire dans les cancers réfractaires de la thyroïde en 2021 : quand, comment, et pourquoi ? Un travail du réseau TUTHYREF 2021 ·Bulletin du Cancer ·Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, Stéphane Bardet, Abir Al Ghuzlan, Isabelle Borget, Françoise Borson‐Chazot, Christine Do Cao, Camille Buffet, Slimane Zerdoud, Myriam Decaussin‐Petrucci, Yann Godbert, Sophie Leboulleux	8
7	Intermittent versus continuous administration of pazopanib in progressive radioiodine refractory thyroid carcinoma: Final results of the randomised, multicenter, open-label phase II trial PAZOTHYR 2021 ·European Journal of Cancer ·Christelle de la Fouchardière, Yann Godbert, Cécile Dalban, F. Illouz, Johanna Wassermann, Christine Do Cao, Stéphane Bardet, Slimane Zerdoud, C. Chougnet, (unknown), Danielle Benisvy, Patricia Niccoli, Laurence Digue, Livia Lamartina, (unknown), Françoise Borson‐Chazot, Julien Gautier, David Pérol, Sophie Leboulleux	11
8	Cystic form of cervical lymphadenopathy in adults. Guidelines of the French Society of Otorhinolaryngology (short version). Part 2–etiological diagnosis procedure: Clinical and imaging assessment 2020 ·European Annals of Otorhinolaryngology Head and Neck Diseases ·L. Santini, Valentin Favier, F. Benoudiba, Gabriel Garcia, Ronan Abgral, Slimane Zerdoud, Gilles Russ, Alexandre Bozec, (unknown), (unknown), R. Garrel, Erwan de Monès	4
9	320P Oligometastatic breast cancer incidence and clinical presentation at diagnosis: About 131 cases 2020 ·Annals of Oncology ·(unknown), C. Chira, (unknown), R. Aziza, (unknown), (unknown), Eva Jouve, Carole Massabeau, Anne Pradines, (unknown), Mony Ung, Slimane Zerdoud, Florence Dalenc	1
10	Multifocal recurrence on the transaxillary robotic thyroidectomy incision 2019 ·European Annals of Otorhinolaryngology Head and Neck Diseases ·É. Chabrillac, Slimane Zerdoud, Sébastien Fontaine, Jérôme Sarini	9
11	Cystic form of cervical lymphadenopathy. Guidelines of the French Society of Otorhinolaryngology - Head and Neck Surgery (SFORL). Part 1: Diagnostic procedures for lymphadenopathy in case of cervical mass with cystic aspect 2019 ·European Annals of Otorhinolaryngology Head and Neck Diseases ·F. Mouawad, (unknown), Gilles Russ, F. Benoudiba, Gabriel Garcia, Ronan Abgral, Slimane Zerdoud, (unknown), (unknown), Erwan de Monès, R. Garrel	2
12	Evaluation of 2 diuretic 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography imaging protocols for intrapelvic cancer 2019 ·The Quarterly Journal of Nuclear Medicine and Molecular Imaging ·Lawrence Dierickx, Laurent Dercle, Léonor Chaltiel, (unknown), (unknown), Slimane Zerdoud, F. Courbon	3
13	Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial 2018 ·The Lancet Diabetes & Endocrinology ·Martin Schlumberger, Sophie Leboulleux, Bogdan Catargi, Désirèe Deandreis, Slimane Zerdoud, Stéphane Bardet, Daniéla Rusu, Yann Godbert, Camille Buffet, Claire Schvartz, Pierre Véra, Olivier Morel, Danielle Benisvy, Claire Bournaud, Marie‐Elisabeth Toubert, A. Kelly, E Benhamou, Isabelle Borget	103
14	Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders 2017 ·Nuclear Medicine Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), Slimane Zerdoud, D. Bastié, (unknown), Philippe Caron, Manuel Bardiès, F. Courbon	15
15	Radiothérapie postopératoire des carcinomes médullaires de la thyroïde à haut risque de rechute locorégionale 2016 ·Cancer/Radiothérapie ·(unknown), Slimane Zerdoud, M. Rives, Anne Laprie, Jérôme Sarini, Solange Grunenwald, Léonor Chaltiel, P. Gräff	6
16	Development of Photoonycholysis with Vandetanib Therapy 2016 ·Skin Appendage Disorders ·(unknown), Slimane Zerdoud, S. Boulinguez, É. Tournier, Jean‐Pierre Delord, Robert Baran, V. Sibaud	7
17	Comparison of an alternative and existing binning methods to reduce the acquisition duration of 4D PET/CT 2014 ·Medical Physics ·(unknown), Cyril Jaudet, (unknown), Hadj Batatia, Lawrence Dierickx, Slimane Zerdoud, (unknown), (unknown), F. Courbon, (unknown)	3
18	Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: Are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome? 2014 ·European Journal of Nuclear Medicine and Molecular Imaging ·Laurent Dercle, Roland Chisin, Samy Ammari, (unknown), M. Ouali, Cyril Jaudet, Jean‐Pierre Delord, Lawrence Dierickx, Slimane Zerdoud, Martin Schlumberger, F. Courbon	16
19	The Sentinel Node Technique Detects Unexpected Drainage Pathways and Allows Nodal Ultrastaging in Early Cervical Cancer: Insights from the Multicenter Prospective SENTICOL Study 2012 ·Annals of Surgical Oncology ·Anne‐Sophie Bats, Patrice Mathevet, Annie Buénerd, (unknown), Eliane Mery-Lamarche, Slimane Zerdoud, Marie‐Aude Le Frère‐Belda, Marc Froissart, Denis Querleu, Alejandra Martínez, Éric Leblanc, Philippe Morice, Émile Daraï, H. Marret, Florence Gillaizeau, Fabrice Lécuru	91
20	Comparison of four strategies of radioiodine ablation in patients with thyroid cancer with low-risk of recurrence: the randomized, prospective ESTIMABL study 2011 ·Laurence Leenhardt, Bogdan Catargi, Isabelle Borget, Slimane Zerdoud, B. Bridji, Stéphane Bardet, Marie‐Elisabeth Toubert, M Schlumberger	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact